Gary R. Erdmann

943 total citations
34 papers, 764 citations indexed

About

Gary R. Erdmann is a scholar working on Public Health, Environmental and Occupational Health, Pulmonary and Respiratory Medicine and Transplantation. According to data from OpenAlex, Gary R. Erdmann has authored 34 papers receiving a total of 764 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Public Health, Environmental and Occupational Health, 9 papers in Pulmonary and Respiratory Medicine and 7 papers in Transplantation. Recurrent topics in Gary R. Erdmann's work include Acute Lymphoblastic Leukemia research (10 papers), Renal Transplantation Outcomes and Treatments (7 papers) and Respiratory and Cough-Related Research (4 papers). Gary R. Erdmann is often cited by papers focused on Acute Lymphoblastic Leukemia research (10 papers), Renal Transplantation Outcomes and Treatments (7 papers) and Respiratory and Cough-Related Research (4 papers). Gary R. Erdmann collaborates with scholars based in United States and Japan. Gary R. Erdmann's co-authors include Bruce Bostrom, Daniel M. Canafax, S. K. Wahba Khalil, Scott A. Gruber, Gary L. C. Chan, G. Scott Giebink, Arthur J. Matas, Paul S. Gaynon, D. M. Canafax and Robert J. Cipolle and has published in prestigious journals such as Blood, Pharmaceutical Research and Transplantation.

In The Last Decade

Gary R. Erdmann

34 papers receiving 745 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Gary R. Erdmann 323 180 138 89 89 34 764
J. Craig Argyle 38 0.1× 62 0.3× 93 0.7× 75 0.8× 7 0.1× 27 643
Arifa Nazneen 77 0.2× 89 0.5× 77 0.6× 28 0.3× 4 0.0× 34 753
Judith Krey Ludviksen 41 0.1× 22 0.1× 94 0.7× 152 1.7× 8 0.1× 41 718
Dan Năvolan 67 0.2× 110 0.6× 112 0.8× 30 0.3× 4 0.0× 75 691
Daniel E. Dulek 35 0.1× 13 0.1× 255 1.8× 18 0.2× 18 0.2× 44 901
Valle Nazar‐Stewart 104 0.3× 32 0.2× 75 0.5× 25 0.3× 27 0.3× 15 926
Ute Gravemann 91 0.3× 35 0.2× 73 0.5× 141 1.6× 4 0.0× 39 805
Paul E. Steele 51 0.2× 42 0.2× 490 3.6× 38 0.4× 4 0.0× 54 1.2k
S P Dix 93 0.3× 57 0.3× 129 0.9× 256 2.9× 9 595
Gillian Marshman 98 0.3× 33 0.2× 144 1.0× 13 0.1× 16 0.2× 45 917

Countries citing papers authored by Gary R. Erdmann

Since Specialization
Citations

This map shows the geographic impact of Gary R. Erdmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary R. Erdmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary R. Erdmann more than expected).

Fields of papers citing papers by Gary R. Erdmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary R. Erdmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary R. Erdmann. The network helps show where Gary R. Erdmann may publish in the future.

Co-authorship network of co-authors of Gary R. Erdmann

This figure shows the co-authorship network connecting the top 25 collaborators of Gary R. Erdmann. A scholar is included among the top collaborators of Gary R. Erdmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary R. Erdmann. Gary R. Erdmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Bostrom, Bruce, Gary R. Erdmann, & Barton A. Kamen. (2003). Systemic Methotrexate Exposure Is Greater After Intrathecal Than After Oral Administration. Journal of Pediatric Hematology/Oncology. 25(2). 114–117. 24 indexed citations
4.
Carlson, James D., et al.. (2001). Bioequivalence evaluation of lansoprazole 30-mg capsules (Lanfast® and Lanzor®) in healthy volunteers. European Journal of Pharmaceutics and Biopharmaceutics. 51(2). 153–157. 16 indexed citations
5.
Canafax, Daniel M., et al.. (1994). Comparison of Two Otitis Media Models for the Study of Middle Ear Antimicrobial Pharmacokinetics. Pharmaceutical Research. 11(6). 855–859. 8 indexed citations
6.
Jossart, Gregg H., Daniel M. Canafax, Gary R. Erdmann, et al.. (1994). Effect of Streptococcus pneumoniae and Influenza A Virus on Middle Ear Antimicrobial Pharmacokinetics in Experimental Otitis Media. Pharmaceutical Research. 11(6). 860–864. 25 indexed citations
7.
Gruber, Scott A., Gary R. Erdmann, Barbara A. Burke, et al.. (1992). MIZORIBINE PHARMACOKINETICS AND PHARMACODYNAMICS IN A CANINE RENAL ALLOGRAFT MODEL OF LOCAL IMMUNOSUPPRESSION1,2. Transplantation. 53(1). 12–19. 13 indexed citations
8.
Erdmann, Gary R., et al.. (1991). Reversed-phase high-performance liquid chromatographic approach to determine total lymphocyte concentrations of 6-thioguanine, methylmercaptopurine and methylthioguanine in humans. Journal of Chromatography B Biomedical Sciences and Applications. 571(1-2). 149–156. 20 indexed citations
9.
Cipolle, Robert J., Donald L. Uden, Scott A. Gruber, et al.. (1990). Evaluation of a Rapid Monitoring System to Study Heparin Pharmacokinetics and Pharmacodynamics. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 10(6). 367–372. 9 indexed citations
10.
Jossart, Gregg H., Gary R. Erdmann, David G. Levitt, et al.. (1990). An Experimental Model for Measuring Middle Ear Antimicrobial Drug Penetration in Otitis Media. Pharmaceutical Research. 7(12). 1242–1247. 18 indexed citations
11.
12.
Chan, Gary L. C., Gary R. Erdmann, Scott A. Gruber, Arthur J. Matas, & Daniel M. Canafax. (1990). Azathioprine Metabolism: Pharmacokinetics of 6‐Mercaptopurine, 6‐Thiouric Acid and 6‐Thioguanine Nucleotides in Renal Transplant Patients. The Journal of Clinical Pharmacology. 30(4). 358–363. 93 indexed citations
13.
Chan, Gary L. C., Gary R. Erdmann, S. A. Gruber, et al.. (1989). Pharmacokinetics of 6-thiouric acid and 6-mercaptopurine in renal allograft recipients after oral administration of azathioprine. European Journal of Clinical Pharmacology. 36(3). 265–271. 17 indexed citations
14.
Gruber, Scott A., William J.M. Hrushesky, Robert J. Cipolle, et al.. (1989). LOCAL IMMUNOSUPPRESSION WITH REDUCED SYSTEMIC TOXICITY IN A CANINE RENAL ALLOGRAFT MODEL. Transplantation. 48(6). 936–943. 15 indexed citations
15.
Canafax, Daniel M., et al.. (1989). Experimental Animal Models for Studying Antimicrobial Pharmacokinetics in Otitis Media. Pharmaceutical Research. 6(4). 279–285. 34 indexed citations
16.
Gruber, Scott A., Daniel M. Canafax, Gary R. Erdmann, et al.. (1989). THE PHARMACOKINETIC ADVANTAGE OF LOCAL 6-MERCAPTOPURINE INFUSION IN A CANINE RENAL TRANSPLANT MODEL1,2. Transplantation. 48(6). 928–935. 8 indexed citations
17.
Erdmann, Gary R., D. M. Canafax, & G. Scott Giebink. (1988). High-performance liquid chromatographic analysis of trimethoprim and sulfamethoxazole in microliter volumes of chinchilla middle ear effusion and serum. Journal of Chromatography B Biomedical Sciences and Applications. 433. 187–195. 22 indexed citations
18.
Gruber, Scott A., Robert J. Cipolle, Daniel M. Canafax, et al.. (1988). An Implantable Pump for Intrarenal Infusion of Immunosuppressants in a Canine Autotransplant Model. Pharmaceutical Research. 5(12). 781–785. 15 indexed citations
19.
Erdmann, Gary R.. (1987). Antibacterial action of Myiasis-causing flies. Parasitology Today. 3(7). 214–216. 30 indexed citations
20.
Erdmann, Gary R.. (1960). On the kidney tolerance of parenterally administered sorbitol solutions. Journal of Molecular Medicine. 38. 1002. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. Craig Argyle Breakdown of academic impact, for papers by Arifa Nazneen Breakdown of academic impact, for papers by Judith Krey Ludviksen Breakdown of academic impact, for papers by Dan Năvolan Breakdown of academic impact, for papers by Daniel E. Dulek Breakdown of academic impact, for papers by Valle Nazar‐Stewart Breakdown of academic impact, for papers by Ute Gravemann Breakdown of academic impact, for papers by Paul E. Steele Breakdown of academic impact, for papers by S P Dix Breakdown of academic impact, for papers by Gillian Marshman
Rankless by CCL
2026